HCV microelimination in harm reduction centres has benefits beyond HCV cure but is hampered by high reinfection rates

HCV microelimination in harm reduction centres has benefits beyond HCV cure but is hampered by high reinfection rates

Background & Aims: Significant scale-up of treatment among people who inject drugs (PWID) is crucial to achieve WHO HCV elimination targets. We explored the impact of on-site HCV diagnosis and treatment on PWID in an externalised hepatology clinic at the biggest harm reduction centre (HRC) i...

Full description

Bibliographic Details
Main Authors: Sabela Lens, Anna Miralpeix, Mont Gálvez, Elisa Martró, Noemi González, Sergio Rodríguez-Tajes, Zoe Mariño, Verónica Saludes, Juliana Reyes-Urueña, Xavier Majó, Joan Colom, Xavier Forns
Format: Article
Language:English
Published: Elsevier 2022-12-01
Series:JHEP Reports
Subjects:
Hepatitis C
Drug users
Antiviral therapy
Dried blood spot testing
High-risk practices
Online Access:http://www.sciencedirect.com/science/article/pii/S2589555922001525

Similar Items

Similar Items